Author Affiliations: Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee (Drs Rice and Wheeler) (email@example.com); and Pulmonary and Critical Care Unit, Massachusetts General Hospital, Boston, Massachusetts (Dr Thompson).
In Reply: The Randomized Trial of Omega-3 Fatty Acids on Top of Modern Therapy After Acute Myocardial Infarction (OMEGA) and the Early Versus Delayed Enteral Nutrition in ALI (EDEN) trial were designed to simultaneously investigate 2 questions regarding enteral nutrition in patients with ALI—the role of n-3 fatty acids, GLA, and antioxidant supplementation, and the risks and benefits of higher and lower volumes of enteral nutrition, respectively.1
Rice TW, Wheeler AP, Thompson BT. Supplementation in Acute Lung Injury—Reply. JAMA. 2012;307(2):144-146. doi:10.1001/jama.2011.1985